1.Oxidative Stress Markers and the Risk of Incident Stroke and Ischemic Heart Disease: A Case-Cohort Study
Shuai GUO ; Hitomi KIMURA ; Kazumasa YAMAGISHI ; Tomomi KIHARA ; Isao MURAKI ; Yoshihiro KOKUBO ; Isao SAITO ; Hiroshi YATSUYA ; Hiroyasu ISO ; Taiki YAMAJI ; Manami INOUE ; Shoichiro TSUGANE ; Norie SAWADA ; Motoki IWASAKI ;
Journal of Stroke 2026;28(2):273-282
Background:
and Purpose To investigate the association between derivatives of reactive oxygen metabolites (d-ROMs), biological antioxidant potential (BAP) and the risk of stroke by subtype, and ischemic heart disease (IHD).
Methods:
We employed a case cohort design consisting of cardiovascular disease cases (n=1,521; stroke, n=1,271; IHD, n=265) and a random sub-cohort (n=4,761) in a large Japanese population-based study. d-ROMs and BAP were measured in plasma samples collected between 1995 and 1999. Hazard ratios (HRs) were estimated using weighted Cox proportional hazards methods according to d-ROMs and BAP quartiles, adjusted for age, sex, area, and potential confounding factors.
Results:
Analysis revealed a positive association between d-ROMs and the risk of total stroke, ischemic stroke, IHD, and the composite outcome of ischemic stroke and IHD. The multivariable HRs and 95% confidence intervals (CIs) for the highest versus lowest quartiles for d-ROMs were 1.34 (95% CI: 1.11–1.63) for total stroke (P for trend<0.001), 1.47 (1.16–1.86) for ischemic stroke (P for trend<0.001), 1.47 (1.02–2.11) for IHD (P for trend=0.072), 1.47 (0.87–2.49) for subarachnoid hemorrhage (P for trend=0.101), and 1.01 (0.72–1.41) for intraparenchymal hemorrhage (P for trend=0.618). In contrast, no significant association was detected between BAP levels and the risk of cardiovascular disease.
Conclusions
Analysis revealed that d-ROMs levels were positively associated with the risk of ischemic stroke and heart disease but not with hemorrhagic stroke.
2.Physical activity and risk of sarcopenia in 6500 community-dwelling Japanese people aged 40-74 years: an 8-year follow-up study.
Shoya WAKANA ; Keiko KABASAWA ; Kaori KITAMURA ; Yumi WATANABE ; Tomoyo KOMATA ; Yumi ITO ; Akemi TAKAHASHI ; Toshiko SAITO ; Ryosaku KOBAYASHI ; Rieko OSHIKI ; Ribeka TAKACHI ; Shoichiro TSUGANE ; Kei WATANABE ; Junta TANAKA ; Ichiei NARITA ; Kazutoshi NAKAMURA
Environmental Health and Preventive Medicine 2025;30():44-44
BACKGROUND AND AIM:
The association between physical activity (PA) and sarcopenia has mostly been investigated in older people, with few studies focused on earlier life stages. The present study aimed to determine whether higher PA levels are associated with a lower sarcopenia risk in middle-aged and early older people.
METHODS:
This was an 8-year follow-up study. Participants were 6,500 community-dwelling adults aged 40-74 years who participated in the baseline questionnaire survey conducted in 2011-2014 in Japan. Levels of total and leisure-time PAs at baseline were assessed using validated metabolic equivalent scores. Multi-frequency bioelectrical impedance analysis and handgrip strength measurement were performed in 2021-2022, and participants with low height-adjusted appendicular lean mass (<20th percentile) and low grip strength were diagnosed as having sarcopenia (outcome). Covariates were demographics, body size, lifestyle, and disease history at baseline.
RESULTS:
The prevalence of sarcopenia was 137/2926 (4.7%) for men and 127/3574 (3.6%) for women. Higher total PA levels were associated with lower odds of sarcopenia (P for trend = 0.0278), with the second highest group having a significantly lower OR (0.51) than the lowest group (reference) in women, but not in men. Regarding leisure-time PA, those engaged in leisure-time vigorous PA had a lower OR of sarcopenia than those who did not (OR = 0.67, P = 0.0625).
CONCLUSION
Higher levels of total PA are associated with a lower risk of sarcopenia in women but not in men, suggesting a sex difference in this association. In addition, high levels of vigorous leisure-time PA may be effective for preventing sarcopenia.
Humans
;
Sarcopenia/epidemiology*
;
Japan/epidemiology*
;
Male
;
Female
;
Middle Aged
;
Aged
;
Follow-Up Studies
;
Independent Living/statistics & numerical data*
;
Exercise
;
Adult
;
Prevalence
;
Risk Factors
;
Hand Strength
;
East Asian People
4.The Murakami Cohort Study of vitamin D for the prevention of musculoskeletal and other age-related diseases: a study protocol.
Kazutoshi NAKAMURA ; Ribeka TAKACHI ; Kaori KITAMURA ; Toshiko SAITO ; Ryosaku KOBAYASHI ; Rieko OSHIKI ; Yumi WATANABE ; Keiko KABASAWA ; Akemi TAKAHASHI ; Shoichiro TSUGANE ; Masayuki IKI ; Ayako SASAKI ; Osamu YAMAZAKI
Environmental Health and Preventive Medicine 2018;23(1):28-28
BACKGROUND:
Age-related musculoskeletal diseases are becoming increasingly burdensome in terms of both individual quality of life and medical cost. We intended to establish a large population-based cohort study to determine environmental, lifestyle, and genetic risk factors of musculoskeletal and other age-related diseases, and to clarify the association between vitamin D status and such diseases.
METHODS:
We targeted 34,802 residents aged 40-74 years living in areas of northern Niigata Prefecture, including Sekikawa Village, Awashimaura Village, and Murakami City (Murakami region). The baseline questionnaire survey, conducted between 2011 and 2013, queried respondents on their lifestyle and environmental factors (predictors), and self-reported outcomes. Plasma 25-hydroxyvitamin D (25[OH]D) concentration, an indicator of vitamin D status, was determined with the Liaison® 25OH Vitamin D Total Assay. The primary outcome of this study was osteoporotic fracture; other outcomes included age-related diseases including knee osteoarthritis, perception of chronic pain, dementia, and long-term care insurance use. Mean ages of men and women were 59.2 (SD = 9.3, N = 6907) and 59.0 (SD = 9.3, N = 7457) years, respectively. From the blood samples provided by 3710 men and 4787 women, mean 25(OH)D concentrations were 56.5 (SD = 18.4) nmol/L (22.6 ng/mL) and 45.4 (SD = 16.5) nmol/L (18.2 ng/mL), respectively.
DISCUSSION
Follow-up surveys are planned every 5 years for 15 years, and incident cases of our targeted diseases will be followed at hospitals and clinics in and nearby the cohort area. We anticipate that we will be able to clarify the association between vitamin D status and multiple disease outcomes in a Japanese population.
Aged
;
Aging
;
Cohort Studies
;
Epidemiologic Research Design
;
Female
;
Humans
;
Incidence
;
Japan
;
epidemiology
;
Male
;
Middle Aged
;
Musculoskeletal Diseases
;
epidemiology
;
prevention & control
;
Predictive Value of Tests
;
Quality of Life
;
Risk Factors
;
Vitamin D
;
analogs & derivatives
;
blood


Result Analysis
Print
Save
E-mail